Biotechnology News

SAN CARLOS, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...

Châtillon, France, le 17 juillet 2026 DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars DBV Technologies...

Châtillon, France, July 17, 2026 DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market:...

Immuneering Corporation Announces Grants of Inducement Awards

EMERYVILLE, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...

INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : CARBIOS (code ISIN FR0011648716) / Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 17 juillet 2026 (18h00 CEST). CARBIOS...

REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) / Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 17 July 2026 (18:00 CEST). CARBIOS, (Euronext...

Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage...

TORONTO, July 17, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (TSX Venture: ARCH and OTCQB: ACHFF) today announced that it has engaged a U.S.-based laboratory specializing in bioengineering to...

Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies. TAIPEI,...